glp-1 comparison of short-acting versus long-acting RAs [Meier et al comparison of glp 1 agonists

Making an Informed Decision: For people seeking affordable, accessible approaches to metabolic support who understand the evidence limitations and have realistic expectations about modest potential benefits, probiotic GLP-1 supplements represent one option in a comprehensive wellness strategy

For patients who have experienced GI adverse events, consider withholding medications in a stepwise manner to determine the causative agent or facilitate tolerance of the GLP-1 receptor agonist

Scope of review: This review explores the impact of DM on cognitive function

Furthermore, the incidence of metabolic syndrome and type 2 diabetes is higher among patients with bipolar disorder than in the general population and is associated with a worse disease course and poor treatment outcomes [187, 188]

Weight Loss Outcomes With Semaglutide Treatment The study found that semaglutide treatment at doses used in randomized clinical trials (1.7 mg and 2.4 mg) was associated with significant weight loss